Citations

Mayo Clinic

Showing 10 of 108599 citations.

HHV‐6 in liver transplantation: A literature review
Phan, Tuan L. , Lautenschlager, Irmeli, Muñoz, Flor M. , Munoz, Flor M , Razonable, Raymund R.

Liver International | June 26, 2017 | Volume: 38 | Issue: 2 | Pages: 210-223

10.1111/liv.13506 | PMID 28650593 Get It

AbstractHuman herpesvirus 6 (HHV‐6A and HHV‐6B) can cause primary infection or reactivate from latency in liver transplant recipients, which can result in a variety of clinical syndromes, including fever, hepatitis, encephalitis and higher rates of graft dysfunction as well as indirect effects including increased risks of mortality, CMV disease, hepatitis C progression and greater fibrosis scores. Although HHV‐6 infection is currently diagnosed by quantifying viral DNA in plasma or blood, biopsy to demonstrate histopathological effects of HHV‐6 remains the gold standard for diagnosis of end‐organ disease. HHV‐6 reactivation may be restricted to the infected organ with no evidence of active infection in the blood. HHV‐6 infections in liver transplant patients are mostly asymptomatic, but clinically significant tissue‐invasive infections have been treated successfully with ganciclovir, foscarnet or cidofovir. Inherited chromosomally integrated HHV‐6 (ciHHV‐6), in either the recipient or the donor organ, may create confusion about systemic HHV‐6 infection. Recipients with inherited ciHHV‐6 may have an increased risk of opportunistic infection and graft rejection. This article reviews the current scientific data on the clinical effects, risk factors, pathogenesis, diagnosis and treatment of HHV‐6 infections in liver transplant recipients.
The Null Effect of Bladder Neck Size on Incontinence Outcomes after Radical Prostatectomy
Tyson, Mark D. , Ark, Jacob , Gregg, Justin R. , Johnsen, Niels V. , Kappa, Stephen F., Lee, Daniel J. , Smith, Joseph A.

Journal of Urology | June 24, 2017 | Volume: 198 | Issue: 6 | Pages: 1404-1408

10.1016/j.juro.2017.06.084 | PMID 28655528 Get It

Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
Nofal, Alaa Al , Viers, Lyndsay D., Javed, Asma , Al Nofal, Alaa

Gynecological Endocrinology | June 24, 2017 | Volume: 33 | Issue: 11 | Pages: 882-887

10.1080/09513590.2017.1342236 | PMID 28649885 Get It

Compound muscle action potential duration in critical illness neuromyopathy
Kramer, Christopher L., Boon, Andrea J. , Harper, C. Michel , Goodman, Brent P.

Muscle & Nerve | June 24, 2017 | Volume: 57 | Issue: 3 | Pages: 395-400

10.1002/mus.25732 | PMID 28646510 Get It

ABSTRACTIntroductionWe sought to determine the specificity of compound muscle action potential (CMAP) durations and amplitudes in a large critical illness neuromyopathy (CINM) cohort relative to controls with other neuromuscular conditions.MethodsFifty‐eight patients with CINM who had been seen over a 17‐year period were retrospectively studied. Electrodiagnostic findings of the CINM cohort were compared with patients with axonal peripheral neuropathy and myopathy due to other causes.ResultsMean CMAP durations were prolonged, and mean CMAP amplitudes were severely reduced both proximally and distally in all nerves studied in the CINM cohort relative to the control groups. The specificity of prolonged CMAP durations for CINM approached 100% if they were encountered in more than 1 nerve.DiscussionProlonged, low‐amplitude CMAPs occur more frequently and with greater severity in CINM patients than in neuromuscular controls with myopathy and axonal neuropathy and are highly specific for the diagnosis of CINM. Muscle Nerve 57: 395–400, 2018
Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy‐organomegaly‐endocrinopathy‐monoclonal protein‐skin changes and chronic inflammatory demyelinating polyradiculoneuropathy
Wang, Wei , Litchy, William J. , Mauermann, Michelle L. , Dyck, P. James B. , Mandrekar, Jay , Klein, Christopher J. , Dispenzieri, Angela , Klein, Christopher J , Mauermann, Michelle L

Muscle & Nerve | June 24, 2017 | Volume: 57 | Issue: 1 | Pages: No page available

10.1002/mus.25731 | PMID 28646568 Get It

ABSTRACTIntroduction: In polyradiculoneuropathy‐organomegaly‐endocrinopathy‐monoclonal protein‐skin changes (POEMS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), limb nerve conduction studies (NCSs) are limited in identifying demyelination and in detecting treatment effects in severely affected patients. Blink R1 latency may improve these assessments. Methods: POEMS and CIDP patients who had undergone NCS and blink reflex were identified. Correlations among R1 latency, limb NCS, and neuropathy impairment scores (NIS) were compared. Results: Among 182 patients (124 POEMS, 58 CIDP) who were identified, R1 prolongation (>13 ms) occurred in 64.3% (65.3% POEMS, 62.1% CIDP). R1 prolongation correlated with more severely affected NCS in both POEMS (ulnar CMAP 2.6 mV vs. 4.5 mV, P = 0.001) and CIDP (2.0 mV vs. 6.1 mV, P < 0.001). In severely affected patients (ulnar CMAP ≤0.5 mV [10%:18/182]), R1 (>13 ms) helped establish demyelination. In 31 patients (16 POEMS, 15 CIDP), the R1 latency changes were concordant with NIS changes in 94% of patients with POEMS and 60% of patients with CIDP. Discussion: Blink R1 latencies are valuable in defining demyelination and detecting improvement in severely affected POEMS and CIDP patients. Muscle Nerve 57: E8–E13, 2018
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time
Hijazi, Ziad , Andersson, Ulrika , Lindbäck, Johan , Granger, Christopher B. , Alexander, John H. , Hanna, Michael G. , Harjola, Veli‐Pekka , Siegbahn, Agneta , Wallentin, Lars , Lindahl, Bertil , Oldgren, Jonas , Gersh, Bernard J. , Hylek, Elaine M. , Lópes, Renato D. , Lindbäck, Johan , Granger, Christopher B

Journal of the American Heart Association | June 24, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1161/jaha.116.004851 | PMID 28645934 Get It

Background Cardiac biomarkers are independent risk markers in atrial fibrillation, and the novel biomarker–based ABC stroke score (age, biomarkers, and clinical history of prior stroke) was recently shown to improve the prediction of stroke risk in patients with atrial fibrillation. Our aim was to investigate the short‐term variability of the cardiac biomarkers and evaluate whether the ABC stroke risk score provides a stable short‐term risk estimate. Methods and Results According to the study protocol, samples were obtained at entry and also at 2 months in 4796 patients with atrial fibrillation followed for a median of 1.8 years in the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. Cardiac troponin I, cardiac troponin T, and N‐terminal pro‐B‐type natriuretic peptide were measured with high‐sensitivity immunoassays. Associations with outcomes were evaluated by Cox regression. C indices and calibration plots were used to evaluate the ABC stroke score at 2 months. The average changes in biomarker levels during 2 months were small (median change cardiac troponin T +2.8%, troponin I +2.0%, and N‐terminal pro‐B‐type natriuretic peptide +13.5%) and within‐subject correlation was high (all ≥0.82). Repeated measurement of cardiac biomarkers provided some incremental prognostic value for mortality but not for stroke when combined with clinical risk factors and baseline levels of the biomarkers. Based on 8702 person‐years of follow‐up and 96 stroke/systemic embolic events, the ABC stroke score at 2 months achieved a similar C index of 0.70 (95% CI, 0.65–0.76) as compared with 0.70 (95% CI, 0.65–0.75) at baseline. The ABC stroke score remained well calibrated using predefined risk classes. Conclusions In patients with stable atrial fibrillation, the variability of the cardiac biomarkers and the biomarker‐based ABC stroke score during 2 months are small. The prognostic information by the ABC stroke score remains consistent and well calibrated with similar good predictive performance if patients are retested after 2 months. Clinical Trial Registration URL: http://www.clinicaltrials.gov . Unique identifier: NCT 00412984.
Cellular functions of WASP family proteins at a glance
Alekhina, Olga , Billadeau, Daniel D. , Billadeau, Daniel D , Burstein, Ezra

Journal of Cell Science | June 23, 2017 | Volume: 130 | Issue: 14 | Pages: 2235-2241

10.1242/jcs.199570 | PMID 28646090 Get It

ABSTRACT Proteins of the Wiskott–Aldrich syndrome protein (WASP) family function as nucleation-promoting factors for the ubiquitously expressed Arp2/3 complex, which drives the generation of branched actin filaments. Arp2/3-generated actin regulates diverse cellular processes, including the formation of lamellipodia and filopodia, endocytosis and/or phagocytosis at the plasma membrane, and the generation of cargo-laden vesicles from organelles including the Golgi, endoplasmic reticulum (ER) and the endo-lysosomal network. Recent studies have also identified roles for WASP family members in promoting actin dynamics at the centrosome, influencing nuclear shape and membrane remodeling events leading to the generation of autophagosomes. Interestingly, several WASP family members have also been observed in the nucleus where they directly influence gene expression by serving as molecular platforms for the assembly of epigenetic and transcriptional machinery. In this Cell Science at a Glance article and accompanying poster, we provide an update on the subcellular roles of WHAMM, JMY and WASH (also known as WASHC1), as well as their mechanisms of regulation and emerging functions within the cell.
Gastrointestinal: Zollinger–Ellison Syndrome: A rare cause of chronic diarrhea and abdominal pain
Anderson, Bradley J. , Sweetser, Seth

Journal of Gastroenterology and Hepatology | June 23, 2017 | Volume: 32 | Issue: 7 | Pages: 1281-1281

10.1111/jgh.13630 | PMID 28639271 Get It

Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Oursler, Merry Jo, Drake, Matthew T. , Clarke, Bart L, Clarke, B.L. , Khosla, Sundeep

Endocrine Reviews | June 23, 2017 | Volume: 38 | Issue: 4 | Pages: 325-350

10.1210/er.2015-1114 | PMID 28651365 Get It